A

A. 2001. on preserving reduced blood sugar. Enhanced blood sugar sensitivity and decreased excitability had been absent in pieces extracted from KD-fed mice missing adenosine A1 receptors (A1Rs); in pieces from normal pets ramifications of the KD could possibly be reversed with blockers of pannexin-1 stations, A1Rs, or KATP stations. Overall, these research reveal a KD sensitizes glucose-based legislation of excitability via purinergic systems in the hippocampus and therefore link essential metabolic and immediate neural ramifications of the KD. check for normalized beliefs. Evoked potential areas between KD and CD or between before and following medications had been weighed against one-way ANOVA. 0.05 was considered significant. Open up in another screen Fig. 1. KD feeding in vivo and reduced blood sugar in vitro limit control and excitability seizure-like activity in rat hippocampus. ACC: Data from hippocampal pieces incubated in decreased (3 mM) blood sugar. DCF: Data from hippocampal pieces incubated in regular (11 mM) blood sugar. A: PS input-output curves demonstrate that hippocampal CA3 in KD-fed rats is normally much less excitable across a variety of arousal intensities, and the utmost response amplitude was decrease significantly. Compact disc (n = 5), KD (n = 20); && 0.01 compared between KD and CD. B: After complementing for preliminary response amplitude, stop of GABAergic inhibition (bicuculline, 10 M) induced seizure-like activity in every pieces (quantified as region under evoked response). The response area was low in slices from KD-fed rats significantly. Compact disc (n = 5), KD (n = 20); *NS, not different significantly; * 0.05 between KD and CD; $$ 0.01 between bicuculline and baseline. C: Acutely raising blood sugar (from 3 mM to 11 mM) augments bicuculline-induced seizure-like activity considerably in the CA3 area of pieces from KD-fed rats, but does not have any effect in pieces from CD-fed rats. For comparability, seizure-like activity to severe glucose [which differed between Compact disc and KD treatment preceding; see (B)] is defined to 100% to create brand-new baselines for better evaluation of acute blood sugar results. n = 4C5; #NS, not really considerably different; ##check); ** 0.01 between KD and Compact disc. D, E: Pieces from KD-fed rats incubated and documented in 11 mM blood sugar showed minimal electrophysiological adjustments in hippocampal pyramidal neurons, during obstruct of GABAergic inhibition even. Compact disc (n = 14), KD (n = 27); & 0.05 between CD and KD; *NS, not really different between CD and KD considerably; $$ 0.01 between baseline and bicuculline. F: When blood sugar was decreased acutely (from 11 mM to 3 mM), there is a decrease in bicuculline-induced excitability just in pieces from KD-fed rats. Compact disc (n = 13), KD (n = 7); #NS, not really considerably different; ## 0.01 weighed against 100% (Mann-Whitney check); * 0.05 between KD and CD. Open in another home window Fig. 3. Acute elevation in blood sugar blocks the KDs influence on hippocampal excitability via an A1R-pannexin-K+ route pathway. All pieces had been incubated in 3 mM blood sugar aCSF and extracellular blood sugar focus was acutely risen to 11 mM blood sugar for 25 min. Bicuculline was requested 20 min before various other medications. A: DPCPX program (1 M) augmented bicuculline-induced seizure-like activity in pieces from KD-fed rats and obstructed 11 mM glucose-induced upsurge in this activity (n = 4). B: Blocking A1Rs, pannexin-1 stations, or KATP stations (DPCPX, 1 M; 10panx, 100 M; tolbutamide, 500 M, respectively) elevated epileptiform activity likewise in pieces from KD-fed rats. The excitatory aftereffect of increased glucose was avoided by all three antagonists acutely. n = 4C5; %% 0.01 compared pre- and postdrug program (Mann-Whitney check); *NS, not really different between baseline and 11 mM glucose considerably; ** 0.01 between baseline and 11 mM blood sugar. RESULTS We given a Compact disc or KD to rats or mice for 13C18 times and prepared severe hippocampal pieces for extracellular field potential recordings in CA3. Evaluation of rat bloodstream plasma indicated significant elevation from the ketone body -hydroxybutyrate at period of euthanization (0.97 0.14 mM KD vs. 0.05 0.02 mM CD, 0.05); also, the common altered PS amplitude prior to the program of bicuculline had not been considerably different between Compact disc and KD groupings (1.00 0.05 mV KD vs. 1.18 0.12 mV CD; 0.05). To keep in vitro circumstances like those in vivo during KD nourishing (steady, low blood sugar), some hippocampal pieces had been incubated and documented in aCSF with blood sugar at a minimal focus (3 mM) (34, 35); various other slices had been incubated in high-glucose aCSF (11 mM; regular for acute pieces). KD nourishing decreased excitability as quantified by PS current/voltage.[PMC free of charge content] [PubMed] [Google Scholar] 49. Enhanced blood sugar sensitivity and decreased excitability had been absent in pieces extracted from KD-fed mice missing adenosine A1 receptors (A1Rs); in pieces from normal pets ramifications of the KD could possibly be reversed with blockers of pannexin-1 stations, A1Rs, or KATP stations. Overall, these research reveal a KD sensitizes glucose-based legislation of excitability via purinergic systems in the hippocampus and therefore link crucial metabolic and immediate neural ramifications of the KD. check for normalized beliefs. Evoked potential areas between Compact disc and KD or between before and after medications were weighed against one-way ANOVA. 0.05 was considered significant. Open up in another home window Fig. 1. KD nourishing in vivo and decreased blood sugar in vitro limit excitability and control seizure-like activity in rat hippocampus. ACC: Data from hippocampal pieces incubated in decreased (3 mM) blood sugar. DCF: Data from hippocampal pieces incubated in regular (11 mM) blood sugar. A: PS input-output curves demonstrate that hippocampal CA3 in KD-fed rats is certainly much less excitable across a variety of excitement intensities, and the utmost response amplitude was considerably lower. Compact disc (n = 5), KD (n = 20); && 0.01 compared between CD and KD. B: After complementing for preliminary response amplitude, stop of GABAergic inhibition (bicuculline, 10 M) induced seizure-like activity in every pieces (quantified as region under evoked response). The response region was reduced considerably in pieces from KD-fed rats. Compact disc (n = 5), KD (n = 20); *NS, not really considerably different; * 0.05 between CD and KD; $$ 0.01 between baseline and bicuculline. C: Acutely raising blood sugar (from 3 mM to 11 mM) augments bicuculline-induced seizure-like activity considerably in the CA3 area of pieces from KD-fed rats, but does not have any effect in pieces from CD-fed rats. For comparability, seizure-like activity ahead of acute blood sugar [which differed between Compact disc and KD treatment; see (B)] is defined to 100% to create brand-new baselines for better evaluation of acute blood sugar results. n = 4C5; #NS, not really considerably different; ##check); ** 0.01 between Compact disc and KD. D, E: Pieces from KD-fed rats incubated and documented in 11 mM blood sugar showed minimal electrophysiological adjustments in hippocampal pyramidal neurons, also during stop of GABAergic inhibition. Compact disc (n = 14), KD (n = 27); & 0.05 between CD and KD; *NS, not really considerably different between Compact UAMC-3203 disc and KD; $$ 0.01 between baseline and bicuculline. F: When blood sugar was decreased acutely (from 11 mM to 3 mM), there is a decrease in bicuculline-induced excitability just in pieces from KD-fed rats. Compact disc (n = 13), KD (n UAMC-3203 = 7); #NS, not really considerably different; ## 0.01 compared with 100% (Mann-Whitney test); * 0.05 between CD and KD. Open in a separate window Fig. 3. Acute elevation in glucose blocks the KDs effect on hippocampal excitability via an A1R-pannexin-K+ channel pathway. All slices were incubated in 3 mM glucose aCSF and extracellular glucose concentration was acutely increased to 11 mM glucose for 25 min. Bicuculline was applied for 20 min before other drugs. A: DPCPX application (1 M) augmented bicuculline-induced seizure-like activity in slices from KD-fed rats and blocked 11 mM glucose-induced increase in this activity (n = 4). B: Blocking A1Rs, pannexin-1 channels, or KATP channels (DPCPX, 1 M; 10panx, 100 M; tolbutamide, 500 M, respectively) increased epileptiform activity similarly in slices from KD-fed rats. The excitatory effect of acutely increased glucose was prevented by all three antagonists. n = 4C5; %% 0.01 compared pre- and postdrug application (Mann-Whitney test); *NS, not significantly different between baseline and 11 mM glucose; ** 0.01 between baseline and 11 mM glucose. RESULTS We fed a CD or KD to rats or mice for 13C18 days and prepared acute hippocampal slices for extracellular field potential recordings in CA3. Analysis of rat blood plasma indicated significant elevation of the ketone body -hydroxybutyrate at time of euthanization (0.97 0.14 mM KD vs. 0.05 0.02 mM CD, 0.05); also, the average adjusted PS amplitude before the application of bicuculline was not significantly different between CD and KD groups (1.00 0.05 mV KD vs. 1.18 0.12 mV CD; 0.05). To maintain in vitro conditions like those in vivo during KD feeding (stable, low blood glucose), some hippocampal slices were incubated and recorded in aCSF with glucose at a low concentration (3 mM) (34, 35); other slices were incubated in high-glucose aCSF (11 mM; typical for acute slices). KD feeding reduced excitability as quantified by PS current/voltage input/output curves, particularly at higher stimulation intensities in 3 mM glucose-incubated slices (Fig. 1A). Furthermore, after incubation in 3 mM glucose, seizure-like activity induced by blocking -aminobutyric acid-mediated (GABAergic) inhibition (bicuculline, 10 M) was diminished.Epilepsia. 42: 1371C1378. reveal that a KD sensitizes glucose-based regulation of excitability via purinergic mechanisms in the hippocampus and thus link key metabolic and direct neural effects of the KD. test for normalized values. Evoked potential areas between CD and KD or between before and after drug treatment were compared with one-way ANOVA. 0.05 was considered significant. Open in a separate window Fig. 1. KD feeding in vivo and reduced glucose in vitro limit excitability and control seizure-like activity in rat hippocampus. ACC: Data from hippocampal slices incubated in reduced (3 mM) glucose. DCF: Data from hippocampal slices incubated in standard (11 mM) glucose. A: PS input-output curves demonstrate that hippocampal CA3 in KD-fed rats is less excitable across a range of stimulation intensities, and the maximum response amplitude was significantly lower. CD (n = 5), KD (n = 20); && 0.01 compared between CD and KD. B: After matching for initial response amplitude, block of GABAergic inhibition (bicuculline, 10 M) induced seizure-like activity in all slices (quantified as area under evoked response). The response area was reduced significantly in slices from KD-fed rats. CD (n = 5), KD (n = 20); *NS, not significantly different; * 0.05 between CD and KD; $$ 0.01 between baseline and bicuculline. C: Acutely increasing glucose (from 3 mM to 11 mM) augments bicuculline-induced seizure-like activity significantly in the CA3 region of slices from KD-fed rats, but has no effect in slices from CD-fed rats. For comparability, seizure-like activity prior to acute glucose [which differed between CD and KD treatment; see (B)] is set to 100% to form new baselines for better comparison of acute glucose effects. n = 4C5; #NS, not significantly different; ##test); ** 0.01 between CD and KD. D, E: Slices from KD-fed rats incubated and recorded in 11 mM glucose showed minor electrophysiological changes in hippocampal pyramidal neurons, even during block of GABAergic inhibition. CD (n = 14), KD (n = 27); & 0.05 between CD and KD; *NS, not significantly different between CD and KD; $$ 0.01 between baseline and bicuculline. F: When glucose was reduced acutely (from 11 mM to 3 mM), there was a reduction in bicuculline-induced excitability only in slices from KD-fed rats. CD (n = 13), KD (n = 7); #NS, not significantly different; ## 0.01 compared with 100% (Mann-Whitney test); * 0.05 between CD and KD. Open in a UAMC-3203 separate window Fig. 3. Acute elevation in glucose blocks the KDs effect on hippocampal excitability via an A1R-pannexin-K+ channel pathway. All slices were incubated in 3 mM glucose aCSF and extracellular glucose concentration was acutely increased to 11 mM glucose for 25 min. Bicuculline was applied for 20 min before other drugs. A: DPCPX application (1 M) augmented bicuculline-induced seizure-like activity in slices from KD-fed rats and blocked 11 mM glucose-induced increase in this activity (n = 4). B: Blocking A1Rs, pannexin-1 channels, or KATP channels (DPCPX, 1 M; 10panx, 100 M; tolbutamide, 500 M, respectively) increased epileptiform activity similarly in slices from KD-fed rats. The excitatory effect of acutely increased glucose was prevented by all three antagonists. n = 4C5; %% 0.01 compared pre- and postdrug application (Mann-Whitney test); *NS, not significantly different between baseline and 11 mM glucose; ** 0.01 between baseline and 11 mM glucose. RESULTS We fed a CD or KD to rats or mice for 13C18 days and prepared acute hippocampal slices for extracellular field potential recordings in CA3. Analysis of rat blood plasma indicated significant elevation of the ketone body -hydroxybutyrate at time of euthanization (0.97 0.14 mM KD vs. 0.05 0.02 mM CD, 0.05); also, the average adjusted PS amplitude before the application of bicuculline was not significantly different between CD and KD groups (1.00 0.05 mV KD vs. 1.18 Rabbit Polyclonal to ABHD14A 0.12 mV CD; 0.05). To maintain in vitro conditions like those in vivo during KD feeding (stable, low blood glucose), some hippocampal slices were incubated and recorded in aCSF with glucose at a low concentration (3 mM) (34, 35); additional slices were incubated in high-glucose aCSF (11 mM; standard for acute slices). KD feeding reduced excitability as quantified by PS current/voltage input/output curves, particularly at higher activation intensities in.[PubMed] [Google Scholar] 44. KD-fed animals were sensitive to small physiological changes in glucose, and showed reduced excitability and seizure propensity. Similar to medical observations, reduced excitability depended on keeping reduced glucose. Enhanced glucose sensitivity and reduced excitability were absent in slices from KD-fed mice lacking adenosine A1 receptors (A1Rs); in slices from normal animals effects of the KD could be reversed with blockers of pannexin-1 channels, A1Rs, or KATP channels. Overall, these studies reveal that a KD sensitizes glucose-based rules of excitability via purinergic mechanisms in the hippocampus and thus link important metabolic and direct neural effects of the KD. test for normalized ideals. Evoked potential areas between CD and KD or between before and after drug treatment were compared with one-way ANOVA. 0.05 was considered significant. Open in a separate windowpane Fig. 1. KD feeding in vivo and reduced glucose in vitro limit excitability and control seizure-like activity in rat hippocampus. ACC: Data from hippocampal slices incubated in reduced (3 mM) glucose. DCF: Data from hippocampal slices incubated in standard (11 mM) glucose. A: PS input-output curves demonstrate that hippocampal CA3 in KD-fed rats is definitely less excitable across a range of activation intensities, and the maximum response amplitude was significantly lower. CD (n = 5), KD (n = 20); && 0.01 compared between CD and KD. B: After coordinating for initial response amplitude, block of GABAergic inhibition (bicuculline, 10 M) induced seizure-like activity in all slices (quantified as area under evoked response). The response area was reduced significantly in slices from KD-fed rats. CD (n = 5), KD (n = 20); *NS, not significantly different; * 0.05 between CD and KD; $$ 0.01 between baseline and bicuculline. C: Acutely increasing glucose (from 3 mM to 11 mM) augments bicuculline-induced seizure-like activity significantly in the CA3 region of slices from KD-fed rats, but has no effect in slices from CD-fed rats. For comparability, seizure-like activity prior to acute glucose [which differed between CD and KD treatment; see (B)] is set to 100% to form fresh baselines for better assessment of acute glucose effects. n = 4C5; #NS, not significantly different; ##test); ** 0.01 between CD and KD. D, E: Slices from KD-fed rats incubated and recorded in 11 mM glucose showed small electrophysiological changes in hippocampal pyramidal neurons, actually during block of GABAergic inhibition. CD (n = 14), KD (n = 27); & 0.05 between CD and KD; *NS, not significantly different between CD and KD; $$ 0.01 between baseline and bicuculline. F: When glucose was reduced acutely (from 11 mM to 3 mM), there was a reduction in bicuculline-induced excitability only in slices from KD-fed rats. CD (n = 13), KD (n = 7); #NS, not significantly different; ## 0.01 compared with 100% (Mann-Whitney test); * 0.05 between CD and KD. Open in a separate windowpane Fig. 3. Acute elevation in glucose blocks the KDs effect on hippocampal excitability via an A1R-pannexin-K+ channel pathway. All slices were incubated in 3 mM glucose aCSF and extracellular glucose concentration was acutely increased to 11 mM glucose for 25 min. Bicuculline was applied for 20 min before additional medicines. A: DPCPX software (1 M) augmented bicuculline-induced seizure-like activity in slices from KD-fed rats and clogged 11 mM glucose-induced increase in this activity (n = 4). B: Blocking A1Rs, pannexin-1 channels, or KATP channels (DPCPX, 1 M; 10panx, 100 M; tolbutamide, 500 M, respectively) improved epileptiform activity similarly in slices from KD-fed rats. The excitatory effect of acutely improved glucose was prevented by all three antagonists. n = 4C5; %% 0.01 compared pre- and postdrug software (Mann-Whitney test); *NS, not significantly different between baseline and 11 mM glucose; ** 0.01 between baseline and 11 mM glucose. RESULTS We fed a CD or KD to rats or mice for 13C18 days and prepared acute hippocampal slices for extracellular field potential recordings in CA3. Analysis of rat blood plasma indicated significant elevation of the ketone body -hydroxybutyrate at time of euthanization (0.97 0.14 mM KD vs. 0.05 0.02 mM CD, 0.05); also, the average adjusted PS amplitude before the application of bicuculline was not significantly different between CD and KD groups (1.00 0.05 mV KD vs. 1.18 0.12 mV CD; 0.05). To maintain in vitro conditions like those in vivo during KD feeding (stable, low blood.